Tratamento da DPOC

Estima-se que 251 milhões de pessoas em todo o mundo sofram de DPOC.1 O tratamento da doença e o levantamento dos recursos que implica tornam-na uma pesada carga social e económica sobre indivíduos, comunidades e sistema global de saúde. A ResMed trabalha com médicos especialistas para desenvolver soluções inovadoras no tratamento de DPOC.

O que dizem os especialistas?

Entrevista, Dr Chris Carlin, JIVD 2018

Podem os meios automáticos e de telemonitorização apoiar e simplificar os percursos da VNI e os cuidados de boa qualidade na DPOC e na SHO?

Entrevista, Pr Gonzalez-Bermejo; ERS 2018

Como fazer a reconciliação da VNI de alta intensidade em casa em pacientes com DPOC.

Non-contractual image of a nasal cannula – only use nasal cannulas recommended by ResMed

Referências:

  1. Organização Mundial da Saúde. www.who.int/news-room/fact-sheets/detail/chronicobstructive-
    pulmonary-disease-(copd) (acesso em 31 de janeiro de 2019)
  2. Baiardini I, Rogliani P, Santus P, Corsico AG, Contoli M, Scichilone N, Di Marco F, Lessi P, Scognamillo C, Molinengo G, Ferri F, Patella V, Fiorentino G, Carone M, Braido F. Disease awareness in patients with COPD: measurement and extent. Int J Chron Obstruct Pulmon Dis. 2019;14:1–11. doi: 10.2147/COPD.S179784  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301728/
  3. Nakken N, Janssen DJA, van den Bogaart EHA, Muris JWM, Vercoulen JH, Custers FL, Bootsma GP, Gronenschild MHM, Wouters EFM, Spruit MA. Knowledge gaps in patients with COPD and their proxies. BMC Pulm Med. 2017;17:136. doi: 10.1186/s12890-017-0481-8 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663121/
  4. Ho T, Cusack RP, Chaudhary N, Satia I, Kurmi OP. Under- and over-diagnosis of COPD: a global perspective. Breathe (Sheff). 2019 Mar;15(1):24-35. doi: 10.1183/20734735.0346-2018  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395975/
  5. Franssen FME, Smid DE, Deeg DJH, Huisman M, Poppelaars J, Wouters EFM, Spruitet MA. The physical, mental, and social impact of COPD in a population-based sample: results from the Longitudinal Aging Study Amsterdam. NPJ Prim Care Respir Med. 2018;28(1):30. doi:10.1038/s41533-018-0097-3  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086825/
  6. Yeatts KB, Lippmann SJ, Waller AE, Hassmiller Lich K, Travers D, Weinberger M, Donohue JF. Population-based burden of COPD-related visits in the ED, return ED visits, hospital admissions, and comorbidity risks. Chest. 2013;144:784–93  https://journal.chestnet.org/article/S0012-3692(13)60594-2/fulltext
  7. Svedsater H et al. Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups. Adv Ther 2017;34(6):1466-1481
  8. Doward L et al. Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes. NPJ Prim Care Respir Med. 2017;27:66
  9. Cook NS et al. Patients’ perspectives on COPD: findings from a social media listening study. ERJ Open Res. 2019;5(1):00128-2018
[myAir]
[myAir]